Patents by Inventor Christophe Bureau

Christophe Bureau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200130948
    Abstract: A method for reconciliation in a drug filling line includes providing a batch number relating to a predetermined batch of containers to be filled with a drug. Each one of the containers is marked with a unique identifier differentiating and/or identifying each container among others. Each unique identifier is stored and associated with the batch number by a processing and control unit, before starting the filling step of each container. Filled containers are flashed by at least one identifier reader to check correspondence between the batch number being processed and each filled container, in order to validate or reject in real time each container with respect to a predetermined batch being processed by the filling line.
    Type: Application
    Filed: June 19, 2018
    Publication date: April 30, 2020
    Inventors: Christophe BUREAU, Tod URQUHART, Pierre-Emmanuel LETEURTRE
  • Publication number: 20190365959
    Abstract: Drug eluting stents, methods of making, using, and verifying long-term stability of the drug eluting stents, and methods for predicting long term stent efficacy and patient safety after implantation of a drug eluting stent are disclosured. In one embodiment, a drug eluting stent may include a stent framework; a drug-containing layer; a drug embedded in the drug-containing layer; and a biocompatible base layer disposed over the stent framework and supporting the drug-containing layer. The drug-containing layer may have an uneven coating thickness. In addition or in alternative, the drug-containing layer may be configured to significantly dissolve/dissipate/disappear between 45 days and 60 days after stent implantation. Stents may reduce, minimize, or eliminate patient risks associated with the implantation of a stent, including, for example, restenosis, thrombosis, and/or MACE.
    Type: Application
    Filed: October 30, 2017
    Publication date: December 5, 2019
    Inventors: Jianhua SUN, Christophe BUREAU, Wenbin CAI, Tianzhu LI, Xiaoran KANG
  • Publication number: 20190223784
    Abstract: An integrated system for injection including an injection device in electronic connection with a communication device is provided. The external communication device may be a handheld electronic device such as a Smartphone or a dedicated reader such as a reader capable of reading information contained on an RFID tag. The injection device includes a needle and a drug delivery portion enclosed within an external housing. Optionally, a plurality of sensors is affixed to the surface of the needle to collect data about the injection and physical characteristics of the patient. The data may be recorded on a data capture module. The electronic chip may be a readable and writable electronic chip such as a non-volatile memory chip. Alternatively, the electronic chip is a passive RFID tag. The injection device may further include a data transmitter for sending information obtained from the data capture module to the external communications device.
    Type: Application
    Filed: April 5, 2019
    Publication date: July 25, 2019
    Inventors: Christophe Bureau, Roderick Hausser, Hervé Monchoix
  • Patent number: 10292641
    Abstract: An integrated system for injection including an injection device (10) in electronic connection with a communication device (A) is provided. The external communication device may be a handheld electronic device such as a Smartphone or a dedicated reader such as a reader capable of reading information contained on an RFID tag. The injection device includes a needle (12) and a drug delivery portion (28) enclosed within an external housing. Optionally, a plurality of sensors (16) is affixed to the surface of the needle to collect data about the injection and physical characteristics of the patient. The data may be recorded on a data capture module (36). The electronic chip may be a readable and writable electronic chip such as a nonvolatile memory chip. The injection device may further include a data transmitter (42) for sending information obtained from the data capture module to the external communications device.
    Type: Grant
    Filed: July 10, 2013
    Date of Patent: May 21, 2019
    Assignee: Becton Dickinson France S.A.S.
    Inventors: Christophe Bureau, Roderick Hausser, Herve Monchoix
  • Publication number: 20190127270
    Abstract: The present invention describes a coating with lubricating and anti-scratch properties, comprising glycidoxypropyltrimethoxysilane and phenyltriethoxysilane. The present invention further describes a varnish product for producing such coating and a glass product, in particular a pharmaceutical primary glass container having such coating. Last, but not least, a method is disclosed for protecting a glass surface.
    Type: Application
    Filed: April 13, 2017
    Publication date: May 2, 2019
    Applicant: NUOVA OMPI S.R.L.
    Inventor: Christophe BUREAU
  • Patent number: 10080843
    Abstract: A method of making a delivery device for therapeutic agent, drug or vaccine. The method includes providing a flat panel wafer, forming a plurality of reservoirs, with each reservoir defining a cavity, within the flat panel wafer, and attaching a cover layer across the plurality of reservoirs. The method also includes filling the plurality of reservoirs with at least one of a therapeutic agent, drug, and vaccine to form a plurality of filled reservoirs, and providing a housing portion adjacent each of the plurality of filled reservoirs to form a composed layer. The method also includes separating the composed layer into a plurality of delivery devices, wherein each delivery device includes a reservoir. The delivery device may be suitable for self-injection use.
    Type: Grant
    Filed: May 5, 2016
    Date of Patent: September 25, 2018
    Assignee: Becton Dickinson France
    Inventor: Christophe Bureau
  • Publication number: 20180251906
    Abstract: The invention relates to a method for grafting an organic film onto an electically conductive or semiconductive surface by electro-reduction of a solution, wherein the solution comprises one diazonium salt and one monomer bearing at least one chain polymerizable functional group. During the electrolyzing process, at least one protocole consisting of an electrical polarization of the surface by applying a variable potential over at least a range of values which are more cathodic that the reduction or peak potential of all diazonium salts in said solution is applied. The invention also relates to an electrically conducting or semiconducting surface obtained by implementing this method. The invention further relates to electrolytic compositions.
    Type: Application
    Filed: November 24, 2017
    Publication date: September 6, 2018
    Inventor: Christophe BUREAU
  • Patent number: 10010676
    Abstract: A method of making a delivery device (10) for therapeutic agent, drug or vaccine is disclosed. The method includes providing a flat panel wafer, forming a plurality of reservoirs, with each reservoir defining a cavity, within the flat panel wafer, and attaching a cover layer (20) across the plurality of reservoirs. The method also includes filling the plurality of reservoirs with at least one of a therapeutic agent, drug, and vaccine to form a plurality of filled reservoirs, and providing a housing portion adjacent each of the plurality of filled reservoirs to form a composed layer. The method also includes separating the composed layer into a plurality of delivery devices, wherein each delivery device includes a reservoir. The delivery device may be suitable for self-injection use.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: July 3, 2018
    Assignee: Becton Dickinson France
    Inventor: Christophe Bureau
  • Publication number: 20180115543
    Abstract: The method for providing an online communication platform for a targeted community of people, by choosing a community of people, and identifying a product accessed by said community of people, said product comprising one or more product units. Providing a product identifier on said product units and providing an online communication platform. The online communication platform is accessed by reading the product identifier using a suitable device or entering the product identifier manually into a suitable piece of software; and the product identifier is the only way for a user to access the online communication platform.
    Type: Application
    Filed: March 8, 2016
    Publication date: April 26, 2018
    Applicant: STEVANATO GROUP S.P.A.
    Inventor: Christophe BUREAU
  • Publication number: 20180082029
    Abstract: Selectively providing information to a targeted community of people by choosing the community to have at least two persons; identifying a product accessed by said community having at least two product units. Then providing at least one unique product identifier for each product; providing a database having sets of information with at least two different units of information; and linking at least one set of information to each unique product identifier. Further assigning each person to at least one group, defining at least two groups; and providing each person with a reader to read said unique product identifier The reader has a request system accessing sets of information based on unique product identifiers. The reader also has a request system having a specific group identifier based on a membership to at least one group and at least one of said information units is selectively provided to said person based on said unique product identifier and said specific group identifier.
    Type: Application
    Filed: March 3, 2016
    Publication date: March 22, 2018
    Applicant: STEVANATO GROUP S.P.A.
    Inventor: Christophe BUREAU
  • Publication number: 20180042738
    Abstract: The present disclosure relates to drug eluting stents, methods of making, using, and verifying long-term stability of the drug eluting stents, and methods for predicting long term stent efficacy and patient safety after implantation of a drug eluting stent. In one embodiment, a drug eluting stent may include a stent framework; a drug-containing layer; a drug embedded in the drug-containing layer; and a biocompatible base layer disposed over the stent framework and supporting the drug-containing layer. The drug-containing layer may have an uneven coating thickness. In addition or in alternative, the drug-containing layer may be configured to significantly dissolve/dissipate/disappear between 45 days and 60 days after stent implantation. Stents of the present disclosure may reduce, minimize, or eliminate patient risks associated with the implantation of a stent, including, for example, restenosis, thrombosis, and/or MACE.
    Type: Application
    Filed: October 30, 2017
    Publication date: February 15, 2018
    Applicant: SINO MEDICAL SCIENCES TECHNOLOGY INC.
    Inventors: Jianhua SUN, Christophe BUREAU, Wenbin CAI, Tianzhu LI, Xiaoran KANG
  • Patent number: 9884142
    Abstract: The present invention provides a drug eluting stent including a metallic stent framework, an electro-grafted primer coating disposed on the stent framework; and a biodegradable polymer coating hosting a drug disposed on the electro-grafted primer coating and a method of manufacturing said biodegradable drug eluting stent.
    Type: Grant
    Filed: March 26, 2013
    Date of Patent: February 6, 2018
    Assignee: ALCHIMEDICS
    Inventors: Christophe Bureau, Ferial Haroun, Elodie Henault
  • Patent number: 9863052
    Abstract: The invention relates to a method for grafting an organic film onto an electrically conductive or semiconductive surface by electro-reduction of a solution, wherein the solution comprises one diazonium salt and one monomer bearing at least one chain polymerizable functional group. During the electrolyzing process, at least one protocols consisting of an electrical polarization of the surface by applying a variable potential over at least a range of values which are more cathodic that the reduction or peak potential of all diazonium salts in said solution is applied. The invention also relates to an electrically conducting or semiconducting surface obtained by implementing this method. The invention further relates to electrolytic compositions.
    Type: Grant
    Filed: June 11, 2014
    Date of Patent: January 9, 2018
    Assignee: ALCHIMEDICS
    Inventor: Christophe Bureau
  • Patent number: 9844631
    Abstract: A self-injection device with a miniaturized drug delivery portion is provided. The device includes a housing (10) having an interior volume and the drug delivery portion (20) has a volume enclosed within the housing. The drug delivery portion includes a reservoir (30) containing a fluid to be delivered to a user and a microneedle (22) in fluid communication with the reservoir and extendable through the housing. The drug delivery portion also includes a drive mechanism for expelling fluid from the reservoir through the microneedle, wherein the volume of the drug delivery portion is less than 40% of the interior volume of the housing. The volume of the drug delivery portion may be less than 30% of the interior volume of the housing.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: December 19, 2017
    Assignee: Becton Dickinson France
    Inventor: Christophe Bureau
  • Publication number: 20160251261
    Abstract: A method of handling of a liquid drug formulation, comprising a step of providing a first primary container and coating the inner surface of the first primary container to be exposed to the formulation with a barrier layer to prevent or at least limiting any escape of material from the inner surface of the first primary container, a step of providing a second primary container and coating the inner surface of the second primary container to be exposed to the formulation with a barrier layer to prevent or at least limit any escape of material from the inner surface of the second primary container, wherein the barrier layer coating the inner surface of the second primary container has the same material composition as the barrier layer coating the inner surface of the first primary container, and a step of transition from handling the formulation filled in the first primary container at a first handling phase to handling the formulation filled in the second primary container at a subsequent handling phase so as
    Type: Application
    Filed: March 12, 2015
    Publication date: September 1, 2016
    Inventor: Christophe Bureau
  • Patent number: D797924
    Type: Grant
    Filed: July 21, 2016
    Date of Patent: September 19, 2017
    Assignee: NUOVA OMPI S.R.L.
    Inventor: Christophe Bureau
  • Patent number: D805637
    Type: Grant
    Filed: July 21, 2016
    Date of Patent: December 19, 2017
    Assignee: NUOVA OMPI S.R.L.
    Inventor: Christophe Bureau
  • Patent number: D808518
    Type: Grant
    Filed: July 21, 2016
    Date of Patent: January 23, 2018
    Assignee: NUOVA OMPI S.R.L.
    Inventor: Christophe Bureau
  • Patent number: D811586
    Type: Grant
    Filed: July 21, 2016
    Date of Patent: February 27, 2018
    Assignee: NUOVA OMPI S.R.L.
    Inventor: Christophe Bureau
  • Patent number: D837826
    Type: Grant
    Filed: August 3, 2016
    Date of Patent: January 8, 2019
    Assignee: Stevanato Group S.P.A.
    Inventor: Christophe Bureau